These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38184150)

  • 1. Effect of six month's treatment with omega-3 acid ethyl esters on long-term outcomes after acute myocardial infarction: The OMEGA-REMODEL randomized clinical trial.
    Bernhard B; Heydari B; Abdullah S; Francis SA; Lumish H; Wang W; Jerosch-Herold M; Harris WS; Kwong RY
    Int J Cardiol; 2024 Mar; 399():131698. PubMed ID: 38184150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Omega-3 Acid Ethyl Esters on Left Ventricular Remodeling After Acute Myocardial Infarction: The OMEGA-REMODEL Randomized Clinical Trial.
    Heydari B; Abdullah S; Pottala JV; Shah R; Abbasi S; Mandry D; Francis SA; Lumish H; Ghoshhajra BB; Hoffmann U; Appelbaum E; Feng JH; Blankstein R; Steigner M; McConnell JP; Harris W; Antman EM; Jerosch-Herold M; Kwong RY
    Circulation; 2016 Aug; 134(5):378-91. PubMed ID: 27482002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of n-3 Fatty Acid Supplements in Elderly Patients After Myocardial Infarction: A Randomized, Controlled Trial.
    Kalstad AA; Myhre PL; Laake K; Tveit SH; Schmidt EB; Smith P; Nilsen DWT; Tveit A; Fagerland MW; Solheim S; Seljeflot I; Arnesen H;
    Circulation; 2021 Feb; 143(6):528-539. PubMed ID: 33191772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic profiling of fatty acid desaturase polymorphisms identifies patients who may benefit from high-dose omega-3 fatty acids in cardiac remodeling after acute myocardial infarction-Post-hoc analysis from the OMEGA-REMODEL randomized controlled trial.
    Kwong RY; Heydari B; Ge Y; Abdullah S; Fujikura K; Kaneko K; Harris WS; Jerosch-Herold M; Antman EM; Seidman JG; Pfeffer MA
    PLoS One; 2019; 14(9):e0222061. PubMed ID: 31532795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin Resistance Modifies the Effects of Omega-3 Acid Ethyl Esters on Left Ventricular Remodeling After Acute Myocardial Infarction (from the OMEGA-REMODEL Randomized Clinical Trial).
    Fujikura K; Heydari B; Ge Y; Kaneko K; Abdullah S; Harris WS; Jerosch-Herold M; Kwong RY
    Am J Cardiol; 2020 Mar; 125(5):678-684. PubMed ID: 31948661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of ω3 supplementation in elderly patients with acute myocardial infarction: design of a prospective randomized placebo controlled study.
    Laake K; Myhre P; Nordby LM; Seljeflot I; Abdelnoor M; Smith P; Tveit A; Arnesen H; Solheim S
    BMC Geriatr; 2014 Jun; 14():74. PubMed ID: 24928284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Omega-3 fatty acid blood levels are inversely associated with cardiometabolic risk factors in HFpEF patients: the Aldo-DHF randomized controlled trial.
    Lechner K; Scherr J; Lorenz E; Lechner B; Haller B; Krannich A; Halle M; Wachter R; Duvinage A; Edelmann F
    Clin Res Cardiol; 2022 Mar; 111(3):308-321. PubMed ID: 34453204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. OMEGA, a randomized, placebo-controlled trial to test the effect of highly purified omega-3 fatty acids on top of modern guideline-adjusted therapy after myocardial infarction.
    Rauch B; Schiele R; Schneider S; Diller F; Victor N; Gohlke H; Gottwik M; Steinbeck G; Del Castillo U; Sack R; Worth H; Katus H; Spitzer W; Sabin G; Senges J;
    Circulation; 2010 Nov; 122(21):2152-9. PubMed ID: 21060071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Omega-3 Fatty Acids and Cardiovascular Disease: An Updated Systematic Review.
    Balk EM; Adams GP; Langberg V; Halladay C; Chung M; Lin L; Robertson S; Yip A; Steele D; Smith BT; Lau J; Lichtenstein AH; Trikalinos TA
    Evid Rep Technol Assess (Full Rep); 2016 Aug; (223):1-1252. PubMed ID: 30307737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Escitalopram vs Placebo Treatment for Depression on Long-term Cardiac Outcomes in Patients With Acute Coronary Syndrome: A Randomized Clinical Trial.
    Kim JM; Stewart R; Lee YS; Lee HJ; Kim MC; Kim JW; Kang HJ; Bae KY; Kim SW; Shin IS; Hong YJ; Kim JH; Ahn Y; Jeong MH; Yoon JS
    JAMA; 2018 Jul; 320(4):350-358. PubMed ID: 30043065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Initial and Serial C-Reactive Protein Levels With Adverse Cardiovascular Events and Death After Acute Coronary Syndrome: A Secondary Analysis of the VISTA-16 Trial.
    Mani P; Puri R; Schwartz GG; Nissen SE; Shao M; Kastelein JJP; Menon V; Lincoff AM; Nicholls SJ
    JAMA Cardiol; 2019 Apr; 4(4):314-320. PubMed ID: 30840024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Icosapent Ethyl Reduces Ischemic Events in Patients With a History of Previous Coronary Artery Bypass Grafting: REDUCE-IT CABG.
    Verma S; Bhatt DL; Steg PG; Miller M; Brinton EA; Jacobson TA; Dhingra NK; Ketchum SB; Juliano RA; Jiao L; Doyle RT; Granowitz C; Gibson CM; Pinto D; Giugliano RP; Budoff MJ; Mason RP; Tardif JC; Ballantyne CM;
    Circulation; 2021 Dec; 144(23):1845-1855. PubMed ID: 34710343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk: The STRENGTH Randomized Clinical Trial.
    Nicholls SJ; Lincoff AM; Garcia M; Bash D; Ballantyne CM; Barter PJ; Davidson MH; Kastelein JJP; Koenig W; McGuire DK; Mozaffarian D; Ridker PM; Ray KK; Katona BG; Himmelmann A; Loss LE; Rensfeldt M; Lundström T; Agrawal R; Menon V; Wolski K; Nissen SE
    JAMA; 2020 Dec; 324(22):2268-2280. PubMed ID: 33190147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. n-3 fatty acids and cardiovascular events after myocardial infarction.
    Kromhout D; Giltay EJ; Geleijnse JM;
    N Engl J Med; 2010 Nov; 363(21):2015-26. PubMed ID: 20929341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in eicosapentaenoic acid and docosahexaenoic acid and risk of cardiovascular events and atrial fibrillation: A secondary analysis of the OMEMI trial.
    Myhre PL; Kalstad AA; Tveit SH; Laake K; Schmidt EB; Smith P; Nilsen DWT; Tveit A; Solheim S; Arnesen H; Seljeflot I
    J Intern Med; 2022 May; 291(5):637-647. PubMed ID: 34982486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex Differences in Omega-3 and -6 Fatty Acids and Health Status Among Young Adults With Acute Myocardial Infarction: Results From the VIRGO Study.
    Lu Y; Ding Q; Xu X; Spatz ES; Dreyer RP; D'Onofrio G; Caulfield M; Nasir K; Spertus JA; Krumholz HM
    J Am Heart Assoc; 2018 May; 7(11):. PubMed ID: 29848494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Omega-3 Fatty Acid Supplementation on Plasma Fibroblast Growth Factor 23 Levels in Post-Myocardial Infarction Patients with Chronic Kidney Disease: The Alpha Omega Trial.
    de Borst MH; Baia LC; Hoogeveen EK; Giltay EJ; Navis G; Bakker SJL; Geleijnse JM; Kromhout D; Soedamah-Muthu SS
    Nutrients; 2017 Nov; 9(11):. PubMed ID: 29137111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Long-term Supplementation With Marine Omega-3 Fatty Acids vs Placebo on Risk of Depression or Clinically Relevant Depressive Symptoms and on Change in Mood Scores: A Randomized Clinical Trial.
    Okereke OI; Vyas CM; Mischoulon D; Chang G; Cook NR; Weinberg A; Bubes V; Copeland T; Friedenberg G; Lee IM; Buring JE; Reynolds CF; Manson JE
    JAMA; 2021 Dec; 326(23):2385-2394. PubMed ID: 34932079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma Omega-3 Fatty Acids and the Risk of Cardiovascular Events in Patients After an Acute Coronary Syndrome in MERLIN-TIMI 36.
    Zelniker TA; Morrow DA; Scirica BM; Furtado JD; Guo J; Mozaffarian D; Sabatine MS; O'Donoghue ML
    J Am Heart Assoc; 2021 Apr; 10(8):e017401. PubMed ID: 33840228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Red blood cell oleic acid levels reflect olive oil intake while omega-3 levels reflect fish intake and the use of omega-3 acid ethyl esters: The Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico-Heart Failure trial.
    Harris WS; Masson S; Barlera S; Milani V; Pileggi S; Franzosi MG; Marchioli R; Tognoni G; Tavazzi L; Latini R;
    Nutr Res; 2016 Sep; 36(9):989-994. PubMed ID: 27632919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.